Recruiting
Phase 1
Phase 2

Mesenchymal Stem Cells

Sponsor:

Thomas Advanced Medical LLC

Code:

NCT04684602

Conditions

Autoimmune Diseases

Cardiovascular Disorders

Diabetes Complications

Integumentary Disease

Musculoskeletal Disorders

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

PrimePro™/ PrimeMSK™

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by Thomas Advanced Medical LLC on 2022-04-29.